Thursday, September 23



Biogen Earnings: BIIB Stock Jumps 1% Higher on Q2 Beats

Biogen (NASDAQ:BIIB) earnings for the second quarter of fiscal year 2020 have BIIB stock on the rise Wednesday morning. This comes after reported revenue of $3.68 billion beat Wall Street's estimate of $3.44 billion. Additionally, the company's reported adjusted earnings per share (EPS) of $10.26 cruised by analysts' expectations of $8.04 for the quarter. Source: Pavel Kapysh / Moreover, the company said GAAP EPS was $9.59 for the period. Here is what else is worth mentioning from the most recent Biogen earnings report. Adjusted EPS was up 12% from $9.15 during Q2 2019. Revenue for the quarter comes in 2% higher compared to $3.62 billion during the same time last year. Operating income of $1.97 billion is less than 1% more year-over-year than $1.96 billio...

Potential Alzheimer’s Drug Not Enough to Excite Biogen Stock Investors

Biogen (NASDAQ:BIIB) looked like it was finally ready to run. After a dismal run over the last few months — with shares shedding over 26% from the April high to June low — Biogen stock finally looked to be back in the bulls' control. Source: Pavel Kapysh / The stock opened higher and tacked on almost 10% on July 8. However, shares closed higher by “just” 4.4%, as investors could not keep the name elevated. While the slip from the session high isn't exactly a death sentence for this name, the poor reaction from it certainly is discouraging. No Belief in Biogen's Alzheimer's Treatment? I have read about Biogen's Alzheimer's treatment for years now. So have other investors, which is why they may have been so excited to bid the stock higher near the open. Th...

4 Top Stock Trades for Thursday: TWTR, NIO, BIIB, SNAP

It was a quiet session on Wednesday, as investors search for direction shortly ahead of earnings season. With that in mind, let's look at a few top stock trades for Thursday. Top Stock Trades for Tomorrow No. 1: Twitter (TWTR) Shares of Twitter (NYSE:TWTR) were burning higher, climbing by more than 10% before backing off some of those gains. The stock was rallying on talks of a potential subscription business, although it's still not clear what the situation is regarding these reports. What is more clear, though, is the chart. Shares were rejected from the $37 area, with Twitter unable to reclaim the June high near $36.94. If it can reclaim $37, it puts the February highs in play near $39 and unlocks the potential to clear $40 and go higher. Should the stock continue to ...